|
⚲
|
| Keyboard |
| Tade Brad L
✚
|
|
|---|---|
| CIK # | 0002030561 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002030561] | |
| 4 | [0002030561] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ADMA Biologics Inc | |
| Tade Brad L |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ADMA Biologics Inc ADMA
Common Stock
|
2026-02-19 | Tax withheld | 6,479 | $16.32 | 105,737 |
|
ADMA Biologics Inc ADMA
Common Stock
|
2025-07-24 | Tax withheld | 7,123 | $17.31 | 123,299 |
|
ADMA Biologics Inc ADMA
Common Stock
|
2025-06-26 | Tax withheld | 9,838 | $18.40 | 181,019 |
|
ADMA Biologics Inc ADMA
Common Stock
|
2025-02-26 | Tax withheld | 5,280 | $15.78 | 83,318 |
|
ADMA Biologics Inc ADMA
Stock Option (right to buy) · derivative
|
2025-02-19 | Grant | 93,023 | $0.00 | |
|
ADMA Biologics Inc ADMA
Common Stock
|
2025-02-19 | Grant | 62,227 | $0.00 | |
|
ADMA Biologics Inc ADMA
Common Stock
|
2024-11-22 | Sell | 15,000 | $21.15 | 317,250 |
|
ADMA Biologics Inc ADMA
Common Stock
|
2024-07-24 | Grant | 72,400 | $0.00 | |
|
ADMA Biologics Inc ADMA
Stock Option (right to buy) · derivative
|
2024-07-24 | Grant | 115,100 | $0.00 |